The Cytochrome P450 Enzyme Responsible for the Production of (Z)-Norendoxifen in vitro.

about

The Cytochrome P450 Enzyme Responsible for the Production of (Z)-Norendoxifen in vitro.

Item

http://www.wikidata.org/entity/Q52758170

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The Cytochrome P450 Enzyme Responsible for the Production of (Z)-Norendoxifen in vitro.

@en

The Cytochrome P450 Enzyme Responsible for the Production of

@nl

type

Item

label

The Cytochrome P450 Enzyme Responsible for the Production of (Z)-Norendoxifen in vitro.

@en

The Cytochrome P450 Enzyme Responsible for the Production of

@nl

prefLabel

The Cytochrome P450 Enzyme Responsible for the Production of (Z)-Norendoxifen in vitro.

@en

The Cytochrome P450 Enzyme Responsible for the Production of

@nl

P1476

The Cytochrome P450 Enzyme Responsible for the Production of (Z)-Norendoxifen in vitro.

@en

P2093

Dabei Tang

http://www.w3.org/2001/XMLSchema#string

Jessica Bo Li Lu

http://www.w3.org/2001/XMLSchema#string

Jianli Ma

http://www.w3.org/2001/XMLSchema#string

Jinzhong Liu

http://www.w3.org/2001/XMLSchema#string

Qingyuan Zhang

http://www.w3.org/2001/XMLSchema#string

Zhaoliang Liu

http://www.w3.org/2001/XMLSchema#string

Zhong Chu

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs

Cytochrome P450 CYP3A5 in the human anterior pituitary gland

Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.

Synthesis of mixed (E,Z)-, (E)-, and (Z)-norendoxifen with dual aromatase inhibitory and estrogen receptor modulatory activities.

The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agents.

Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6.

Inhibition of cytochrome p450 enzymes by the e- and z-isomers of norendoxifen.

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.

Design and synthesis of norendoxifen analogues with dual aromatase inhibitory and estrogen receptor modulatory activities

Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer.

P31

scholarly article

P356

10.1002/CBDV.201700287

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28834279

http://www.w3.org/2001/XMLSchema#string